[팜뉴스=이석훈 기자] Dalim Biotech (CEO Jeong Jong-seop, Kim Sang-ki) announced on the 28th that it will launch the high-dose vitamin D complex nutrient ‘Dicamax Everyone’ in April.
Starting with ‘Dicamax 1000 tablets’ in 2005, Dalim Biotech is leading the vitamin D drug market through a pipeline that can meet the needs of medical staff and consumers by combining various ingredients and capacities.
Incorporating this specialized drug research and development know-how, it introduced ‘Dicamax Everyone’, which can be easily purchased at pharmacies as a general medicine, so that modern people can easily fill vitamin D and nutrients lacking.
In addition to vitamin D and calcium, which are essential elements for bone health, per tablet, vitamin B and vitamin C, which are necessary for fatigue recovery and vitality enhancement, and magnesium, which is an essential cofactor for vitamin D metabolism and essential for sugar and lipid metabolism, help with immune function. It contains zinc which gives Taking ‘Dicamax Everyone’ tablets twice a day can help supplement nutrients needed by modern people.
Recently, a research team from the University of Exeter in the UK and the University of Calgary in Canada followed up with 12,000 American seniors for 10 years and found that vitamin D supplements help prevent dementia.
Dalim Biotech CEO Kim Sang-ki said, “For modern people who are increasingly unable to get enough sunlight due to increased indoor activities and air pollution, we have launched Dicamax Everyone, which can expect various effects of vitamin D as well as bone health.” We will strive to become a pharmaceutical company that researches and develops various vitamin D products that are suitable for you.”